We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




RF Ablation Reduces Bone Cancer Pain

By HospiMedica staff writers
Posted on 29 Oct 2002
An international clinical study has shown that radio-frequency (RF) ablation can significantly reduce pain and enhance quality of life for patients whose cancer has spread to the bone. More...
The study was presented at the 2002 annual meeting of the American Society of Clinical Oncology in Orlando, FL (USA).

RF ablation has been used for several years to treat liver and kidney cancer. In the new study, researchers at the Mayo Clinic (Rochester, MN, USA) found that RF ablation can be equally effective in killing cancer cells that cause pain in the bone. In addition to the Mayo Clinic, the study included nine other medical centers in the United States, Italy, Germany and France..

The study showed that 95% of the 43 patients with incurable cancer who were treated with the RF ablation procedure experienced significant pain relief and had improved quality of life. All of the study participants had previously received other standard treatments for pain but achieved minimal relief. Before RF ablation treatment, the pain these patients experienced averaged 7.5 on a scale of one to 10, with 10 being the worst level of unbearable pain. The pain was reduced an average of 50 % eight weeks after the procedure and to an average score of one at 24 weeks following the procedure. Researchers continue to follow-up patients and have found that many of the surviving patients continue to have reduced pain one year after the initial RF ablation procedure.

The RF ablation procedure takes about 30 to 60 minutes to perform. The patient is given a light general anesthetic, and a thin needle is inserted through the skin and guided by computed tomography or ultrasound imaging to the target area. An intense heat is transmitted through the tip of the needle, killing the nerve endings and much of the cancer tissue, thereby alleviating the pain.

The RF ablation system used in the study was developed by Rita Medical Systems, Inc. (Mountain View, CA, USA). The system has been cleared by the US Food and Drug Administration (FDA) for the treatment of pain in cancer patients. Rita Medical provided partial funding for the research.




Related Links:
Rita Medical
Mayo Clinic

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.